Trial Profile
Randomised, open study of bosentan or sildenafil in patients with chronic thromboembolic pulmonary hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Mar 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary) ; Sildenafil (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 18 Mar 2015 New trial record